Literature DB >> 21722237

Rabies postexposure prophylaxis in a UK travel clinic: ten years' experience.

Limin Wijaya1, Lisa Ford, David Lalloo.   

Abstract

BACKGROUND: In 2009, 58.6 million UK residents traveled abroad. Of these, 49.5 million (84.5%) visits were to Europe and North America and 9.1 million (15.5%) were to other parts of the world. Rabies is widely distributed and continues to be a major public health issue in many developing countries. The UK is free of rabies in carnivore host species, although cases of rabies in bats have been reported. This study examined the rabies postexposure prophylaxis (PEP) service from 2000 to July 2009 at the Liverpool School of Tropical Medicine.
METHODS: Medical records of patients who attended the clinic for rabies PEP were reviewed.
RESULTS: During the study period, 139 patients were treated for possible rabies exposure. The mean age was 35 years. Thailand and Turkey each accounted for 31 (22.3%) cases. Sixty-nine (49.6%) of those seen were due to dog bites. Most injuries involved a lower limb (n = 67, 48.2%) or hands (n = 26, 18.7%). Eighty-six (61.9%) cases had initiated rabies PEP overseas, but only 3 of the 78 (3.8%) meeting UK criteria for rabies immunoglobulin (RIG) received it while overseas. Only an additional 11 patients received RIG on return to the UK; most were seen more than 7 days after initiation of PEP. The median time from exposure to receiving rabies PEP was 1 day (range: 0-1,720). Only 14 (10.1%) had received preexposure rabies vaccination.
CONCLUSIONS: The majority of travelers seeking PEP at this clinic initiated treatment overseas. Most had not received RIG abroad, when it would have been appropriate. Initiation of appropriate treatment is often delayed and is a concern to those without preexposure rabies immunization. In view of the scarcity of RIG, travelers need to be aware of the risks, consider preexposure immunization, and present early for PEP.
© 2011 International Society of Travel Medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21722237     DOI: 10.1111/j.1708-8305.2011.00522.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  6 in total

1.  Rabies in travelers.

Authors:  Philippe Gautret; Philippe Parola
Journal:  Curr Infect Dis Rep       Date:  2014-03       Impact factor: 3.725

2.  Animal-associated exposure to rabies virus among travelers, 1997-2012.

Authors:  Philippe Gautret; Kira Harvey; Prativa Pandey; Poh Lian Lim; Karin Leder; Watcharapong Piyaphanee; Marc Shaw; Susan C McDonald; Eli Schwartz; Douglas H Esposito; Philippe Parola
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

3.  Rabies post-exposure prophylaxis started during or after travel: A GeoSentinel analysis.

Authors:  Philippe Gautret; Kristina M Angelo; Hilmir Asgeirsson; David G Lalloo; Marc Shaw; Eli Schwartz; Michael Libman; Kevin C Kain; Watcharapong Piyaphanee; Holly Murphy; Karin Leder; Jean Vincelette; Mogens Jensenius; Jesse Waggoner; Daniel Leung; Sarah Borwein; Lucille Blumberg; Patricia Schlagenhauf; Elizabeth D Barnett; Davidson H Hamer
Journal:  PLoS Negl Trop Dis       Date:  2018-11-13

4.  Rabies post-exposure prophylaxis of overseas travelers in the international travel clinic of the national medical center from 2006 to 2012, Korea.

Authors:  Jong Hyun Park; Chang Hyu Lee; Youn Kyoung Won; Bum Sik Chin; Hyung Sik Shin; Jae Yoon Kim
Journal:  Infect Chemother       Date:  2014-03-21

5.  Tour leaders' knowledge of and attitudes toward rabies vaccination, Taiwan.

Authors:  Chiao-Yu Huang; Hsien-Liang Huang; Shao-Yi Cheng; Chia-Wen Lu; Long-Teng Lee; Tai-Yuan Chiu; Kuo-Chin Huang
Journal:  Emerg Infect Dis       Date:  2014-01       Impact factor: 6.883

Review 6.  Rabies in nonhuman primates and potential for transmission to humans: a literature review and examination of selected French national data.

Authors:  Philippe Gautret; Jesse Blanton; Laurent Dacheux; Florence Ribadeau-Dumas; Philippe Brouqui; Philippe Parola; Douglas H Esposito; Hervé Bourhy
Journal:  PLoS Negl Trop Dis       Date:  2014-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.